Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice-Reference-Cited by-同舟云学术

Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice

Published:2012-11 Issue:11 Volume:32 Page:873-883
ISSN:0271-5317
Container-title:Nutrition Research
language:en
Short-container-title:Nutrition Research

Author:

Park Jin-Hee,Davis Keith R.,Lee Gunsup,Jung Manyong,Jung Yuchul,Park Jungan,Yi Sang-Yeop,Lee Myung-Ah,Lee Sukchan,Yeom Chang-Hwan,Kim Jin

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Treatment of advanced non-small-cell lung cancer: a review of current randomizedclinical trials and an examination of emerging therapies;Cancer Control,2002

3. Taxol dose intensification and its clinical implications;Sarosy;J Natl Med Assoc,1993

4. Paclitaxel in cancer therapy;Mekhail;Expert Opin Pharmacother,2002

5. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species;Alexandre;Cancer Res,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study;Advances and Applications in Bioinformatics and Chemistry;2024-02

2. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel;Tissue and Cell;2023-08

3. Naringin and naringenin counteract taxol-induced liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation;Environmental Science and Pollution Research;2023-07-19

4. Naringin and naringenin counteract taxol-induced hepatic liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation;2023-03-23

5. PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer;2023-03-23